This issue of The Oncology Nurse-APN/PA (TON), our first of the new year, features a selection of insightful topics that we hope you will find useful when caring for patients with cancer.
The University of Washington (UW) Medical Center in Seattle is a leading academic medical center, with specialties in cardiac care, cancer care and stem-cell transplantation, obstetrics (including high-risk neonatal intensive care), orthopedic care, and solid organ transplantation.
The annual meetings of the American Society of Hematology (ASH) and the San Antonio Breast Cancer Symposium (SABCS) took place in December 2014, attracting US and international oncologists interested in the latest research on basic science and clinical medicine. The following articles are a selection of highlights from these meetings.
This patient vignette portrays the self-blame, suffering, and personal pain that a diagnosis of lung cancer may precipitate in patients who smoked cigarettes for a significant part of their life. Lung cancers are the leading cause of cancer deaths in the United States
Many experienced oncology nurses who are retiring or approaching retirement possess knowledge about oncology patient care that comes from years of experience.
In the Nurses’ Health Study 2 (NHS2), it was found that nurses who had “ever” worked rotating night shifts had a 20% increased risk of sleeping fewer than 7 hours per night on average, compared with 0 nurses who had “never” worked night shifts.
Early integration of palliative care into oncology programs improves quality of life for patients and caregivers, increases prognostic understanding, and demonstrates survival benefits while substantially reducing costs...
Cancer-related cachexia is a debilitating condition that has had no effective treatment thus far. Its symptoms include loss of lean body mass, as well as muscle wasting and loss of appetite.
Routine surveillance imaging of asymptomatic patients in first remission after treatment for diffuse large B-cell lymphoma offers little clinical benefit at substantial cost, according to Scott F. Huntington, MD, of Abramson Cancer Center, University of Pennsylvania, Philadelphia, and colleagues.
There’s a lot we don’t know about lung cancer screening,” according to Denise Aberle, MD... However, certain measures can be taken to lower false-positive and overdiagnosis rates, lessen costs, ameliorate patient suffering, and correctly identify screening cohorts, she asserted.
Page 1 of 2
Results 1 - 10 of 11